Skip to content
Lower risk Medical device recall · FDA · Published November 4, 2024

Siemens Atellica CI Analyzer Recall: False Test Results Risk

Siemens Healthcare recalls Atellica CI Analyzer (catalog 10947347) due to potential false elevated sodium, potassium and chloride test results from incorrect diluent volume display.

🇺🇸 FDA recall #Z-0597-2025Medical deviceSiemens Healthcare ›
Take action

Contact the company

Recalling firmSiemens Healthcare Diagnostics, Inc.511 Benedict Ave · Tarrytown, NY 10591-5005
✎ GovInfoNow plain-language explainer

Siemens Healthcare is recalling Atellica CI Analyzers with catalog number 10947347 because the device may show remaining diluent volume incorrectly. This could cause blood test results for sodium, potassium, and chloride to appear falsely elevated, potentially affecting medical decisions. Read more at govinfonow.com/recall/53580-siemens-atellica-ci-analyzer-recall-false-test-results-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/53580-siemens-atellica-ci-analyzer-recall-false-test-results-risk · Updated August 18, 2026 · FDA enforcement record: FDA #Z-0597-2025

Cite this page

“Siemens Atellica CI Analyzer Recall: False Test Results Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/53580-siemens-atellica-ci-analyzer-recall-false-test-results-risk. Based on FDA recall #Z-0597-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0597-2025%22&limit=1).

The FDA announced on Nov. 4, 2024, that Siemens Healthcare Diagnostics is recalling Atellica CI Analyzers due to a potential hazard causing falsely elevated Sodium, Potassium, and Chloride test results. The agency issued recall number Z-0597-2025 for the voluntary Class II action affecting 559 units distributed worldwide.

How to tell if you have it

  • Brand: Siemens Healthcare
  • Product: Atellica CI Analyzer
  • Catalog Number: 10947347
  • UDI-DI Number: 630414229560
  • Software version: 1.28.51

The hazard

The Atellica CI Analyzer may fail to decrease the IMT Diluent volume remaining percentage as expected, potentially leaving the diluent empty while still displaying that volume remains. This malfunction can cause Sodium (Na), Potassium (K), and Chloride (Cl) test results to be falsely elevated. Quality Control materials demonstrate the same behavior.

Context

GovInfoNow's records show Siemens Healthcare Diagnostics, Inc. has 150 other recalls on record since June 7, 2017. Other recent recalls of similar products include Siemens Atellica CH RCRP Test (Aug. 17, 2026), Beckman Coulter Emit 2000 Quinidine Assay (July 13, 2026), and Siemens Atellica CH Urine Albumin Recall (July 6, 2026). Additional recent recalls of similar products include Beckman Coulter DxH Diluent Recall (Nov. 10, 2025), Diagnostica Stago Asserachrom HPIA Kit Recall (Dec. 15, 2025), and Medica Capillary Tubes Recall (Dec. 31, 2025).

How to tell if you have this one

Check for the catalog number 10947347 on the Atellica CI Analyzer. The device was sold with software version 1.28.51 and UDI-DI number 630414229560.

  • Brand
    Siemens Healthcare
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Device Status

    Verify if the analyzer shows the correct diluent volume by checking the display for accurate percentage remaining.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide distribution - US Nationwide and the countries of Austria, Bangladesh, Bulgaria, Canada, Chile, Colombia, Croatia, Czech Republic, Ecuador, Egypt, France, Germany, Greece, Hong Kong, Hungary, India, Iraq, Israel, Italy, Japan,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 37 days after the firm started it.

1. Firm started the recall: Nov 4, 202412. FDA classified it Class II: Dec 4, 202423. Published in FDA’s Enforcement Report: Dec 11, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0597-2025 (November 4, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0597-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA